Previously, we have written that access to lives is important to any pharmacy, and the narrow, preferred networks that have become vogue in Medicare Part D are an example of an outside influence that can impact this access. The theory, of course, is that being in a narrow network will drive patients to a participating pharmacy, thereby increasing its business. The decrease in reimbursement that accompanies preferred status is theoretically offset by the pharmacy’s ability to generate the revenue from these new patients. But does this theory withstand scrutiny? Continue reading The Flip Side of Access to Lives